A recent study using proteomics to identify blood markers for atopic AD found that CD6 protein levels in serum are significantly elevated in AD patients compared to psoriasis patients and healthy controls, thus suggesting that CD6 could be a potential biomarker specific to AD [67,68]. Here, CD6 is linked to Alzheimer disease.